Fox Chase Cancer Center

This study is testing whether giving two approved bladder cancer drugs less frequently can still control the disease while potentially reducing side effects. It involves 60 adults with advanced bladder cancer that has spread or cannot be surgically removed. The main goal is to se…

This study is testing whether combining two existing drugs, nivolumab and ramucirumab, can help control advanced lung cancer that has grown again after a patient's prior immunotherapy. It will enroll 36 adults with this specific type of cancer to see if the combination is safe an…

This study is testing whether combining two existing drugs, nivolumab and axitinib, is safe and effective for treating advanced kidney cancer. It will involve about 98 patients, including those who have had prior treatment and those who have not. The first part finds the safest d…

This study is testing if a modified schedule of two standard chemotherapy combinations is easier for older adults to tolerate while still controlling advanced pancreatic cancer. It is for patients over 65 who are newly diagnosed and have not yet received treatment for cancer that…

This early-stage study is testing whether a lower, potentially safer dose of radiation can effectively treat advanced solid tumors when combined with a drug called 5-aminolevulinic acid (ALA). The drug is meant to make cancer cells more sensitive to the radiation, which could hel…